W
William J. Tremaine
Researcher at Mayo Clinic
Publications - 290
Citations - 26053
William J. Tremaine is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Ulcerative colitis & Inflammatory bowel disease. The author has an hindex of 80, co-authored 282 publications receiving 24233 citations. Previous affiliations of William J. Tremaine include University of Paris & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Collagenous colitis and lymphocytic colitis.
TL;DR: The most recently recognized and least understood forms of inflammatory bowel disease are two types of idiopathic microscopic colitis-collagenous colitis and lymphocytic colitis.
Journal ArticleDOI
Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010.
TL;DR: There were significant racial and ethnic differences in the incidence and temporal trends of IBD over the last four decades in this US population-based cohort.
Journal ArticleDOI
Outcomes of Patients With Microscopic Colitis Treated With Corticosteroids: A Population-Based Study
Nicole Gentile,Adil A. Abdalla,Sahil Khanna,Thomas C. Smyrk,William J. Tremaine,William A. Faubion,Patricia P. Kammer,William J. Sandborn,Edward V. Loftus,Darrell S. Pardi +9 more
TL;DR: Patients with MC often respond to corticosteroid therapy, but with a high relapse rate, and patients treated with budesonide had a higher response rate and a lower risk of recurrence than prednisone.
Journal ArticleDOI
Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota
Siddhant Yadav,Siddharth Singh,Jithinraj Edakkanambeth Varayil,W. Scott Harmsen,Alan R. Zinsmeister,William J. Tremaine,Mark D.P. Davis,David A. Wetter,Jean-Frederic Colombel,Edward V. Loftus +9 more
TL;DR: Patients with IBD were approximately 9 times more likely to develop HS than the general population, with a female predisposition.
Journal ArticleDOI
Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center
Lukasz Kwapisz,Laura E. Raffals,David H. Bruining,Darrell S. Pardi,William J. Tremaine,Sunanda V. Kane,Konstantinos A. Papadakis,Nayantara Coelho-Prabhu,John B. Kisiel,Valerie Heron,William A. Faubion,Edward V. Loftus +11 more
TL;DR: The global incidence of inflammatory bowel disease has increased considerably during the past few decades, and despite the current treatments available, many patients do not achieve remission.